about
Effects of two different strategies of fluid administration on inflammatory mediators, plasma electrolytes and acid/base disorders in patients undergoing major abdominal surgery: a randomized double blind study.Identification of biomarkers for diagnosis and progression of MS by MALDI-TOF mass spectrometry.CSF neurofilament and N-acetylaspartate related brain changes in clinically isolated syndrome.Serum Gelatinases Levels in Multiple Sclerosis Patients during 21 Months of Natalizumab Therapy.Interplay between Matrix Metalloproteinase-9, Matrix Metalloproteinase-2, and Interleukins in Multiple Sclerosis PatientsVaginal Lactoferrin Modulates PGE2, MMP-9, MMP-2, and TIMP-1 Amniotic Fluid Concentrations.Balanced and unbalanced solutions modulate the release of Matrix Metalloproteinase-9 (MMP-9) from neutrophils in response to inflammatory stimuli: an in vitro studyAnti-ApoA-1 IgG serum levels predict worse poststroke outcomes.Matrix metalloproteinase-2 (MMP-2) generates soluble HLA-G1 by cell surface proteolytic shedding.Mutual relationship between serum ferroxidase activity and hemoglobin levels in elderly individuals.Serum osteopontin levels are upregulated and predict disability after an ischaemic stroke.Treatment with recombinant tissue plasminogen activator (r-TPA) induces neutrophil degranulation in vitro via defined pathways.N-acetylaspartate and neurofilaments as biomarkers of axonal damage in patients with progressive forms of multiple sclerosis.Leptin/adiponectin ratio predicts poststroke neurological outcome.TIMP-1 resistant matrix metalloproteinase-9 is the predominant serum active isoform associated with MRI activity in patients with multiple sclerosis.Potential relevance of cerebrospinal fluid and serum levels and intrathecal synthesis of active matrix metalloproteinase-2 (MMP-2) as markers of disease remission in patients with multiple sclerosis.Serum paraoxonase and arylesterase activities of paraoxonase-1 (PON-1), mild cognitive impairment, and 2-year conversion to dementia: A pilot study.Evaluation of total, ceruloplasmin-associated and type II ferroxidase activities in serum and cerebrospinal fluid of multiple sclerosis patients.Low-grade systemic inflammation is associated with functional disability in elderly people affected by dementia.Testing a Combination of Markers of Systemic Redox Status as a Possible Tool for the Diagnosis of Late Onset Alzheimer's DiseaseHydroxyethyl Starch 130/0.4 Binds to Neutrophils Impairing Their Chemotaxis through a Mac-1 Dependent InteractionMatrix metalloproteinase-9 activity detected in body fluids is the result of two different enzyme formsDevelopment, optimization and validation of an absolute specific assay for active myeloperoxidase (MPO) and its application in a clinical context: role of MPO specific activity in coronary artery diseaseTRAIL and Ceruloplasmin Inverse Correlation as a Representative Crosstalk between Inflammation and Oxidative StressInfluence of 6-aminonicotinamide (6AN) on Leishmania promastigotes evaluated by metabolomics: Beyond the pentose phosphate pathwayChanges in Adipose Tissue Distribution and Association between Uric Acid and Bone Health during Menopause Transition"Bridging the Gap" Everything that Could Have Been Avoided If We Had Applied Gender Medicine, Pharmacogenetics and Personalized Medicine in the Gender-Omics and Sex-Omics Era
P50
Q33589199-58950690-6ACC-4BD4-BD95-6AE0D3A213FAQ33877162-22ED3DE3-CECF-4743-8389-1B2F81CCC505Q36840016-C719765B-BFA1-44EF-B85D-99E82409C873Q37009992-7188EA1A-203D-4549-BFE6-14FE1560EB97Q37171985-67880E49-0407-4AAD-B5C4-ED485BB62530Q37411630-67C360CE-9A35-47ED-8425-61CD46879B8CQ38712559-7A8E8DE7-E5D9-4D07-8603-D07B9ADE6405Q38753862-376A91A5-3C94-49B6-815D-E09361865C7AQ39143880-0E5174DF-795C-43B1-99FD-B85DD0F18F19Q39729695-E3A2B626-F6A7-4CC8-B3F3-134DC1DD6C12Q41353520-CE92631A-E78F-4E81-AC34-CA6272F70DB2Q41588199-BFD7DCAD-CA33-469E-9210-E36D1F57FCA2Q42683530-FA316F3D-13BA-436E-89CD-B670346CB46FQ48132154-42C8DE88-47B1-4423-8788-650E091F4754Q48338849-645D53EA-69D2-41E4-B8C0-3145C2573E9CQ50781209-9DB8C9CB-C169-4335-837F-078F2151D0E9Q50853367-BB65E9C6-481F-48CE-AE54-695CB4C23FF0Q50863436-A44F2317-A124-4429-A0D1-DD77DAFEC504Q55250117-7D50945F-867D-41EE-AE95-A0B0A717B913Q57115637-01F4A1E7-E1A0-4B4C-9110-CE8F5C4D119BQ64260024-09802C0C-6E3F-4DF1-861A-2E585948902CQ83463129-6FA6BA26-43AD-4595-A5C2-7B7FF693F424Q89593035-DE894E11-D3E0-4A3A-B4C4-3C0299DAFBEDQ91151111-6204E4B0-14BD-4F91-8527-B330BD73C8E2Q91251010-6EE6FB65-AC71-4B24-8EDA-E4C6B4E6B45AQ92051274-C2D4A666-E5DE-4E10-8CCE-0DC345DBF9B1Q92445909-718E14D8-65D1-4548-8F47-DC5A2CABCA4D
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Alessandro Trentini
@ast
Alessandro Trentini
@en
Alessandro Trentini
@es
Alessandro Trentini
@nl
type
label
Alessandro Trentini
@ast
Alessandro Trentini
@en
Alessandro Trentini
@es
Alessandro Trentini
@nl
prefLabel
Alessandro Trentini
@ast
Alessandro Trentini
@en
Alessandro Trentini
@es
Alessandro Trentini
@nl
P1053
G-6215-2011
P106
P1153
26533540800
P21
P31
P3829
P3835
alessandro-trentini
P496
0000-0003-3579-7921